NASDAQ:ACRS | EBITDA | Aclaris Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$22.09M
2025-12-31-$22.63M
2025-03-31-$17.96M
2024-12-31-$99.53M
2024-03-31-$18.69M
2023-12-31-$3.82M
2023-03-31-$29.72M
2022-12-31-$28.89M
2022-03-31-$18.7M
2021-12-31-$22.7M
2021-03-31-$28.24M
2020-12-31-$14.01M
2020-03-31-$14.93M
2019-12-31-$17.23M
2019-03-31-$24.83M
2018-12-31-$23.09M
2018-03-31-$30.73M
2017-12-31-$7.2M
2017-03-31-$12.88M
2016-12-31-$11.59M

Annual EBITDA

DateEBITDA
2025-12-31-$75.92M
2024-12-31-$141.13M
2023-12-31-$96.49M
2022-12-31-$89.06M
2021-12-31-$88.8M
2020-12-31-$49.59M
2019-12-31-$104.65M
2018-12-31-$82.9M
2017-12-31-$53.96M
2016-12-31-$48.45M
2015-12-31-$20.58M